These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11976419)
1. Biodefense. New anthrax vaccine gets a green light. Enserink M; Marshall E Science; 2002 Apr; 296(5568):639-40. PubMed ID: 11976419 [No Abstract] [Full Text] [Related]
2. Results of a safety and immunogenicity study of an early-stage investigational rPA102 vaccine as compared to the FDA licensed anthrax vaccine (anthrax vaccine adsorbed (AVA. BioThrax)). Hannesschlager JR Vaccine; 2007 Apr; 25(17):3247. PubMed ID: 17234308 [No Abstract] [Full Text] [Related]
3. Anthrax vaccine begins a new round of tests. Marshall E Science; 2002 Jan; 295(5554):427-9. PubMed ID: 11799216 [No Abstract] [Full Text] [Related]
4. [Selected research problems of anthrax vaccine development]. Zakowska D; Kocik J; Bartoszcze M Przegl Epidemiol; 2009; 63(4):505-12. PubMed ID: 20120948 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a subunit vaccine against Bacillus anthracis. Chichester JA; Musiychuk K; de la Rosa P; Horsey A; Stevenson N; Ugulava N; Rabindran S; Palmer GA; Mett V; Yusibov V Vaccine; 2007 Apr; 25(16):3111-4. PubMed ID: 17280756 [TBL] [Abstract][Full Text] [Related]
6. Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines. Parreiras PM; Sirota LA; Wagner LD; Menzies SL; Arciniega JL Vaccine; 2009 Jul; 27(33):4537-42. PubMed ID: 19501205 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial. Gorse GJ; Keitel W; Keyserling H; Taylor DN; Lock M; Alves K; Kenner J; Deans L; Gurwith M Vaccine; 2006 Aug; 24(33-34):5950-9. PubMed ID: 16797805 [TBL] [Abstract][Full Text] [Related]
8. Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain. Flick-Smith HC; Waters EL; Walker NJ; Miller J; Stagg AJ; Green M; Williamson ED Microb Pathog; 2005 Jan; 38(1):33-40. PubMed ID: 15652293 [TBL] [Abstract][Full Text] [Related]
9. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use. Fasanella A; Tonello F; Garofolo G; Muraro L; Carattoli A; Adone R; Montecucco C Vaccine; 2008 Oct; 26(45):5684-8. PubMed ID: 18775462 [TBL] [Abstract][Full Text] [Related]
10. Anthrax. 'Borrowed immunity' may save future victims. Enserink M Science; 2002 Feb; 295(5556):777. PubMed ID: 11823609 [No Abstract] [Full Text] [Related]
11. A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection. Hepler RW; Kelly R; McNeely TB; Fan H; Losada MC; George HA; Woods A; Cope LD; Bansal A; Cook JC; Zang G; Cohen SL; Wei X; Keller PM; Leffel E; Joyce JG; Pitt L; Schultz LD; Jansen KU; Kurtz M Vaccine; 2006 Mar; 24(10):1501-14. PubMed ID: 16271808 [TBL] [Abstract][Full Text] [Related]
12. CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques. Klinman DM; Xie H; Little SF; Currie D; Ivins BE Vaccine; 2004 Jul; 22(21-22):2881-6. PubMed ID: 15246624 [TBL] [Abstract][Full Text] [Related]
13. Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits. Ribot WJ; Powell BS; Ivins BE; Little SF; Johnson WM; Hoover TA; Norris SL; Adamovicz JJ; Friedlander AM; Andrews GP Vaccine; 2006 Apr; 24(17):3469-76. PubMed ID: 16519970 [TBL] [Abstract][Full Text] [Related]
14. Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine. Chabot DJ; Ribot WJ; Joyce J; Cook J; Hepler R; Nahas D; Chua J; Friedlander AM Vaccine; 2016 Jul; 34(34):4012-6. PubMed ID: 27329184 [TBL] [Abstract][Full Text] [Related]
15. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli. Sloat BR; Cui Z Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937 [TBL] [Abstract][Full Text] [Related]
17. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens. Sloat BR; Shaker DS; Le UM; Cui Z FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342 [TBL] [Abstract][Full Text] [Related]
18. Bioterrorism. Vaccines for biodefense: a system in distress. Cohen J; Marshall E Science; 2001 Oct; 294(5542):498-501. PubMed ID: 11641476 [No Abstract] [Full Text] [Related]